286 related articles for article (PubMed ID: 6198383)
1. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
Muul LM; Gately MK
J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
[TBL] [Abstract][Full Text] [Related]
2. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
3. Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro.
Gately MK; Wilson DE; Wong HL
J Immunol; 1986 Feb; 136(4):1274-82. PubMed ID: 2418110
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
Rodgers KE; Grayson MH; Ware CF
J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
Thiele DL; Lipsky PE
J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
[TBL] [Abstract][Full Text] [Related]
6. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
Stanková J; Rola-Pleszczynski M
J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
[TBL] [Abstract][Full Text] [Related]
7. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
8. Loss of specificity in cytolytic T lymphocyte clones obtained by limit dilution culture of Ly-2+ T cells.
Shortman K; Wilson A; Scollay R
J Immunol; 1984 Feb; 132(2):584-93. PubMed ID: 6197466
[TBL] [Abstract][Full Text] [Related]
9. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
Yamamoto RS; Ware CF; Granger GA
J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806
[TBL] [Abstract][Full Text] [Related]
10. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
11. Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
Leeuwenberg JF; Spits H; Tax WJ; Capel PJ
J Immunol; 1985 Jun; 134(6):3770-5. PubMed ID: 2580895
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.
Gately MK; Glaser M; Dick SJ; Mettetal RW; Kornblith PL
J Natl Cancer Inst; 1982 Dec; 69(6):1245-54. PubMed ID: 6183477
[TBL] [Abstract][Full Text] [Related]
13. Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system.
Charpentier B; Michelson S; Martin B
J Immunol; 1986 Jul; 137(1):330-6. PubMed ID: 2423608
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
15. Involvement of T3 and T8 molecules in human T cell receptor function. Anti-T3 or anti-T8 antibodies do not block the antigen-dependent activation of a subset of alloreactive cytolytic T cell precursors.
Moretta A; Pantaleo G; Mingari MC; Moretta L
Eur J Immunol; 1985 Aug; 15(8):803-8. PubMed ID: 3161744
[TBL] [Abstract][Full Text] [Related]
16. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
17. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
Santoli D; Francis MK; Matera L
Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824
[TBL] [Abstract][Full Text] [Related]
20. Cloned human cytotoxic T lymphocytes develop anomalous killer cell function.
Burns GF; Triglia T; Werkmeister JA
Clin Exp Immunol; 1986 Dec; 66(3):558-65. PubMed ID: 3494555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
